Aspirin in 2022: A New Aspirin for a New Chapter
Dr. Neha J. Pagidipati, Dr. Jacqueline E. Tamis-Holland, Dr. Dominick J. Angiolillo and Dr. C. Michael Gibson Discuss: Aspirin in 2022: A New Aspirin for a New Chapter – Clarifying Aspirin Therapy in Secondary Prevention and DAPT for the Practicing Clinician: A Town Hall
Full Town Hall
Dr. Dominick J. Angiolillo discusses the Latest FDA approved Aspirin- PL-ASA
Dr. Neha J. Pagidipati discusses Apririn Use in Secondary Prevention-Patients with Diabetes and/or Obesity
Dr. Jacqueline E. Tamis-Holland discusses Guideline Recommendations for Aspirin Use after Coronary Revascularization- DAPT-SAPT what do the New Guidelines Tell Us
Loading…
Reload document 
Open in new tab Disclosures:
